Schedule 13G ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,689,292
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-001559
- Form type
- SC 13G
- Filer
- OncoMed Pharmaceuticals Inc
- CIK
- CIK 1302573
- Filed
- Jan 09, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership